Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)
Recruiting now
Conditions studied: Acute Coronary Syndrome, Coronary Bypass Stenosis
In brief
The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)
Key facts
- Study ID
- NCT04783701
- Run by
- University Hospital, Linkoeping
- People needed
- 360
- Starts
- 2021-05-17
- Expected to finish
- 2026-03-15
- Last updated by the study team
- 2025-12-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Previously included in TACSI-trial
You may not qualify if…
- Highly irregular heart rhythm (i.e. atrial fibrillation)
- Chronic kidney disease with estimated glomerular filtration rate (eGFR) <45ml/min/1,73m2
- Body weight >120 kg
- Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
- Not able to communicate
- Not willing to participate
Where it is running
- University Hospital Linköping — Linköping, Östergötland County, Sweden (enrolling)
- Department of Heart Disease, Haukeland University Hospital — Bergen, Norway
- St Olavs University Hospital — Trondheim, Norway
- Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine — Gothenburg, Sweden
- Dep of Vascular and Thoracic Surgery — Örebro, Sweden
- Department of Cardiothoracic Surgery Karolinska University Hospital — Stockholm, Sweden
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.